Professional Practice Committee: Standards of Medical Care in Diabetes—2022 (Diabetes Care)
Diabetes News
Category: Guidelines
All Wales Advice on SGLT-2 Inhibitors in Type 2 Diabetes and Cardiovascular Disease
Consultation
Determinants of treatment modification before and after implementation of the updated 2015 NICE guideline on type 2 diabetes: a retrospective cohort study
Our results indicate that a first step towards tailored prescribing has been made. However, not all determinants that are important to consider when prescribing second-line glucose lowering agents were of influence on general practitioners’ prescribing (Diabetes Research and Clinical Practice)
Dapagliflozin with insulin for treating type 1 diabetes
Technology appraisal guidance [TA597] Published date: 28 August 2019 Last updated: 12 February 2020 (NICE)
Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?
In this article, the authors review the study designs and results of CV outcomes trials conducted with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists and discuss how these may affect clinical practice (Clinical Diabetes)
Operational Delivery of the Multi-Disciplinary Care Pathway for Diabetic Foot Problems
The aim of this document is to provide a framework for the operational delivery of hospital Trust based diabetic foot services. Ensuring that patients with acute diabetic foot disease receive the same high quality of care irrespective of where they present (Diabetes UK)
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema
This article issues an urgent call for the review of the current DM classification system toward the consensus on a new, more useful system (Diabetes Care)
The new NICE guidelines for type 2 diabetes – a critical analysis
The latest NICE guidelines for the management of type 2 diabetes are now available for consultation. They contain sensible recommendations regarding lifestyle, patient education, monitoring and targets. Unfortunately, the pharmacotherapy section shows a distinct failure of common sense (The British Journal of Diabetes & Vascular Disease)
NICE guideline consultations
Obesity – working with local communities: draft guidance consultation
Registered stakeholders for this guidance are invited to comment on the provisional recommendations via this website (NICE)
Glycosmedia is also available as an App: